Skip to Content
Merck
  • Investigation of substrate specificity of sialidases with membrane mimetic glycoconjugates.

Investigation of substrate specificity of sialidases with membrane mimetic glycoconjugates.

Glycoconjugate journal (2019-12-06)
Sonia Tomar, Xue-Long Sun
ABSTRACT

Sialidases or neuraminidases play important roles in various physiological and pathological processes by cleaving terminal sialic acids (Sias) (desialylation) from the glycans of both glycoproteins and glycolipids. To understand the biological significance of desialylation by sialidases, it is important to investigate enzyme specificity with native substrate in biological membrane of cells. Herein, we report a membrane-mimicking system with liposome ganglioside conjugates containing different lipids for evaluating substrate specificity of sialidase and the lipid effect on the enzyme activity. Briefly, liposomes of phosphatidylcholine (PC) and cholesterol with ganglioside (GM3 or GM1) along with different percentage of phosphatidylserine (PS) or phosphatidylethanolamine (PE) were prepared and characterized. Their desialylation profiles with Arthrobacter ureafaciens (bacterial) sialidase and H1N1 (influenza viral) sialidase were quantified by HPLC method. A diversity of substrate preference was found for both bacterial and viral sialidase to the liposome ganglioside conjugate platform. The apparent Km and Vmax were dependent on the type of lipid. These results indicate that the intrinsic characteristics of the membrane-like system affect the sialidase specificity and activity. This biomimetic substrate provides a better tool for unravelling the substrate specificity and the biological function of sialidases and for screening of functional sialidase inhibitors as well.

MATERIALS
Product Number
Brand
Product Description

Avanti
16:0 PC (DPPC), Avanti Polar Lipids
Avanti
16:0 PC (DPPC), Avanti Polar Lipids
Avanti
Ganglioside GM3 (Bovine Milk), Avanti Polar Lipids